12 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
Profiles of Antidiabetic ... AACE 2018 #Antidiabetic ... #DecisionAid #Orals ... #DM2 #Diabetes ... Endocrinology #Pharmacology
Oral Antidiabetics

#Diabetes #Medications #Oral #Pharmacology #Sulfonylurea #metformin
Oral Antidiabetics ... #Diabetes #Medications ... #Oral #Pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... to treat Type 2 Diabetes ... There is an ORAL ... #Pharmacology #Dosing ... #Diabetes #DM2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... - Prevents GLP ... @AmyChung #Oral ... #Management #pharmacology ... #DM2 #DMII #Classification
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... Choice -Diabetes ... metformin, SGLT-i, GLP1 ... #Type2 #DM2 #PatientInfo ... Reduction #Costs #Pharmacology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... /ambcarerx #Diabetes ... Combination #Tablets #Oral ... #DM2 #Pharmacology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Most effective oral ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... DPP-4 inhibitor, GLP ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... GLP1 agonist! ... the injectable GLP1 ... #semaglutide #Diabetes ... #Pharmacology #